UPDATED: J&J releases more Doxil, its popular cancer med that has been dogged by supply issues | PharmaBoardroom
written on 24.03.2014
Tags:
,

UPDATED: J&J releases more Doxil, its popular cancer med that has been dogged by supply issues

TAGS: ,

Johnson & Johnson's Janssen, which has struggled to maintain ready supplies of its ovarian cancer treatment Doxil, has released a new lot of the popular drug. The injectable cancer med was produced through an "alternative manufacturing approach" in which the now-closed Ben Venue plant in Ohio made the bulk product and another manufacturer finished it off.

Latest Report